UROPHARMA LIMITED

Active Norwich

Manufacture of medical and dental instruments and supplies

5 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
U

UROPHARMA LIMITED

Manufacture of medical and dental instruments and supplies

Founded 25 May 2012 Active Norwich, England 5 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
Accounts Submitted 17 Oct 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 18 Jul 2025 Next due 21 Jun 2026 1 month remaining
Net assets £987K £936K 2024 year on year
Total assets £1M £132K 2024 year on year
Total Liabilities £503K £804K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

5 Enterprise House, Norwich Research Park Colney Lane Colney Norwich NR4 7UG England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for UROPHARMA LIMITED (08083943), an active life sciences and medical technology company based in Norwich, England. Incorporated 25 May 2012. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£45.74k

Increased by £1.56k (+4%)

Net Assets

£987.25k

Increased by £935.79k (+1818%)

Total Liabilities

£503.29k

Decreased by £804.15k (-62%)

Turnover

N/A

Employees

5

Increased by 2 (+67%)

Debt Ratio

34%

Decreased by 62 (-65%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 199,537,100 Shares £2.39m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 Nov 202418,500,000£185k£0.01
9 Dec 202240,000,000£400k£0.01
23 Dec 202047,504,400£475k£0.01
20 Aug 2019500£5£0.01
20 Aug 201931,275,000£313k£0.01

Officers

Officers

1 active 2 resigned
Status
Sharkey, Andrew NeilDirectorBritishEngland681 Feb 2024Active

Shareholders

Shareholders (1)

Uropharma, Inc
100.0%
204,651,401

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Scott Glickman

American

Active
Notified 4 Oct 2017
Residence England
DOB November 1949
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Howard Terence Shapland

Ceased 4 Oct 2017

Ceased

Scott Glickman

Ceased 4 Oct 2017

Ceased

Uropharma, Inc.

Ceased 4 Oct 2017

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Mar 2026AddressChange Registered Office Address Company With Date Old Address New Address
17 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
18 Jul 2025Confirmation StatementConfirmation statement made on 7 Jun 2025 with updates
17 Jul 2025CapitalAllotment of shares (GBP 2,046,514.01) on 7 Nov 2024
27 May 2025OfficersAppointment of Mr Mark Edward Donaldson as director on 1 Feb 2024
18 Mar 2026 Address

Change Registered Office Address Company With Date Old Address New Address

17 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

18 Jul 2025 Confirmation Statement

Confirmation statement made on 7 Jun 2025 with updates

17 Jul 2025 Capital

Allotment of shares (GBP 2,046,514.01) on 7 Nov 2024

27 May 2025 Officers

Appointment of Mr Mark Edward Donaldson as director on 1 Feb 2024

Recent Activity

Latest Activity

Change Registered Office Address Company With Date Old Address New Address

1 months ago on 18 Mar 2026

Annual accounts made up to 31 Dec 2024

6 months ago on 17 Oct 2025

Confirmation statement made on 7 Jun 2025 with updates

9 months ago on 18 Jul 2025

Allotment of shares (GBP 2,046,514.01) on 7 Nov 2024

9 months ago on 17 Jul 2025

Appointment of Mr Mark Edward Donaldson as director on 1 Feb 2024

11 months ago on 27 May 2025